Skip to main content
In stock|Targeted Therapy

Defactinib

Oncology TypeSolid Tumour
Drug Class / MechanismFocal Adhesion Kinase (FAK) Inhibitor
No Image
Description

Defactinib is classified as a Focal Adhesion Kinase (FAK) Inhibitor, sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic CategoryTargeted Therapy
Oncology TypeSolid Tumour

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3